AXID AR Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Axid Ar, and when can generic versions of Axid Ar launch?
Axid Ar is a drug marketed by Haleon Us Holdings and is included in one NDA.
The generic ingredient in AXID AR is nizatidine. There are seven drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the nizatidine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Axid Ar
A generic version of AXID AR was approved as nizatidine by EPIC PHARMA LLC on July 5th, 2002.
Summary for AXID AR
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 27 |
Formulation / Manufacturing: | see details |
DailyMed Link: | AXID AR at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for AXID AR
US Patents and Regulatory Information for AXID AR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Haleon Us Holdings | AXID AR | nizatidine | TABLET;ORAL | 020555-001 | May 9, 1996 | OTC | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for AXID AR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Haleon Us Holdings | AXID AR | nizatidine | TABLET;ORAL | 020555-001 | May 9, 1996 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for AXID AR
See the table below for patents covering AXID AR around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Denmark | 164056 | ⤷ Try a Trial | |
Ireland | 51603 | IMPROVEMENTS IN OR RELATING TO 2,4-DISTRIBUTED THIAZOLE DERIVATIVES | ⤷ Try a Trial |
European Patent Office | 0049618 | IMPROVEMENTS IN OR RELATING TO 2,4-DISUBSTITUTED THIAZOLE DERIVATIVES | ⤷ Try a Trial |
Finland | 813058 | ⤷ Try a Trial | |
Germany | 3171819 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |